Regulations.gov document
Intended Use PR - Response to AdvaMed Request to Extend Comment Period
Other · FDA-2015-N-2002 · posted Nov 17, 2020
Key facts
| Document ID | FDA-2015-N-2002-2035 |
|---|---|
| Title | Intended Use PR - Response to AdvaMed Request to Extend Comment Period |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2015-N-2002 |
| Posted | Nov 17, 2020 |
| Comment period opens | Nov 17, 2020 |
At a glance
- 1,000+ Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: